The results include the notice of the Minister of Health from 30 August 2019, effective 1st of September 2019.
We track the Minister of Health’s reimbursement decisions and AHTAPol’s statements and recommendations for drugs with no reimbursed equivalents. With our PREDECIZER approach, we analyzed the decision-making practice of the 12-month period from the latest notice compared to the 12-month period of the preceding notice.
The full presentation is available at the following link:
If you have any questions about this analysis, please e-mail us at development(at)inar.pl or call +48 502 315 778
Analysis of the Reimbursement Decision-Making Practice in Poland (September 2019)
